FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015182248> ?p ?o ?g. }

• W2015182248 endingPage "52" @default.
• W2015182248 startingPage "46" @default.
• W2015182248 abstract "To evaluate the feasibility of first-pass contrast-enhanced magnetic resonance angiography (MRA) using ferumoxytol in humans.First-pass and equilibrium phase MRA were performed using ferumoxytol in one healthy volunteer and 11 patients with a fast three-dimensional spoiled gradient recalled (SPGR) pulse sequence. The examined vessels included carotid arteries, thoracic aorta, abdominal aorta, and peripheral arteries. A dose of either 71.6 micromol Fe/kg (n = 9), or 35.8 micromol Fe/kg (n = 3) was used. Based on a phantom study, the agent with initial concentration of 537.2 micromol Fe/mL was diluted by either four-fold (134.3 micromol Fe/mL) or eight-fold (67.1 micromol Fe/mL) for first-pass MRA.All subjects completed their studies without adverse events. First-pass MRA showed selective arterial enhancement, with both arterial and venous enhancement on delayed acquisitions. Selective venous enhancement could be obtained by subtraction of arterial phase images from equilibrium phase images. The findings in ferumoxytol MRA were consistent with the results of original vascular tests.Our preliminary experience supports the feasibility of first-pass MRA with ferumoxytol. Satisfactory arterial enhancement during first-pass imaging is obtained with injection of diluted contrast agent. With ferumoxytol, arteries and veins can be selectively depicted in a single exam." @default.
• W2015182248 created "2016-06-24" @default.
• W2015182248 creator A5000480052 @default.
• W2015182248 creator A5000522168 @default.
• W2015182248 creator A5006014674 @default.
• W2015182248 creator A5014566663 @default.
• W2015182248 creator A5043460764 @default.
• W2015182248 creator A5071961210 @default.
• W2015182248 creator A5081177550 @default.
• W2015182248 creator A5086109337 @default.
• W2015182248 date "2004-12-20" @default.
• W2015182248 modified "2023-10-14" @default.
• W2015182248 title "First‐pass contrast‐enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)‐based blood pool agent" @default.
• W2015182248 cites W1964084354 @default.
• W2015182248 cites W1966228017 @default.
• W2015182248 cites W1978460391 @default.
• W2015182248 cites W1980990502 @default.
• W2015182248 cites W1981051426 @default.
• W2015182248 cites W1981616235 @default.
• W2015182248 cites W1997140154 @default.
• W2015182248 cites W2005228562 @default.
• W2015182248 cites W2007671469 @default.
• W2015182248 cites W2022280660 @default.
• W2015182248 cites W2031054493 @default.
• W2015182248 cites W2043638187 @default.
• W2015182248 cites W2052825225 @default.
• W2015182248 cites W2053305614 @default.
• W2015182248 cites W2057229445 @default.
• W2015182248 cites W2057545473 @default.
• W2015182248 cites W2058103515 @default.
• W2015182248 cites W2062773625 @default.
• W2015182248 cites W2083775147 @default.
• W2015182248 cites W2083843873 @default.
• W2015182248 cites W2088691844 @default.
• W2015182248 cites W2093013610 @default.
• W2015182248 cites W2111350768 @default.
• W2015182248 cites W2142676833 @default.
• W2015182248 cites W2159117098 @default.
• W2015182248 cites W2171752072 @default.
• W2015182248 doi "https://doi.org/10.1002/jmri.20235" @default.
• W2015182248 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15611942" @default.
• W2015182248 hasPublicationYear "2004" @default.
• W2015182248 type Work @default.
• W2015182248 sameAs 2015182248 @default.
• W2015182248 citedByCount "211" @default.
• W2015182248 countsByYear W20151822482012 @default.
• W2015182248 countsByYear W20151822482013 @default.
• W2015182248 countsByYear W20151822482014 @default.
• W2015182248 countsByYear W20151822482015 @default.
• W2015182248 countsByYear W20151822482016 @default.
• W2015182248 countsByYear W20151822482017 @default.
• W2015182248 countsByYear W20151822482018 @default.
• W2015182248 countsByYear W20151822482019 @default.
• W2015182248 countsByYear W20151822482020 @default.
• W2015182248 countsByYear W20151822482021 @default.
• W2015182248 countsByYear W20151822482022 @default.
• W2015182248 countsByYear W20151822482023 @default.
• W2015182248 crossrefType "journal-article" @default.
• W2015182248 hasAuthorship W2015182248A5000480052 @default.
• W2015182248 hasAuthorship W2015182248A5000522168 @default.
• W2015182248 hasAuthorship W2015182248A5006014674 @default.
• W2015182248 hasAuthorship W2015182248A5014566663 @default.
• W2015182248 hasAuthorship W2015182248A5043460764 @default.
• W2015182248 hasAuthorship W2015182248A5071961210 @default.
• W2015182248 hasAuthorship W2015182248A5081177550 @default.
• W2015182248 hasAuthorship W2015182248A5086109337 @default.
• W2015182248 hasBestOaLocation W20151822481 @default.
• W2015182248 hasConcept C104293457 @default.
• W2015182248 hasConcept C126322002 @default.
• W2015182248 hasConcept C126838900 @default.
• W2015182248 hasConcept C143409427 @default.
• W2015182248 hasConcept C2778212899 @default.
• W2015182248 hasConcept C2778286760 @default.
• W2015182248 hasConcept C2779980429 @default.
• W2015182248 hasConcept C2780643987 @default.
• W2015182248 hasConcept C2909801847 @default.
• W2015182248 hasConcept C2989005 @default.
• W2015182248 hasConcept C2994044699 @default.
• W2015182248 hasConcept C33923547 @default.
• W2015182248 hasConcept C71924100 @default.
• W2015182248 hasConcept C94375191 @default.
• W2015182248 hasConceptScore W2015182248C104293457 @default.
• W2015182248 hasConceptScore W2015182248C126322002 @default.
• W2015182248 hasConceptScore W2015182248C126838900 @default.
• W2015182248 hasConceptScore W2015182248C143409427 @default.
• W2015182248 hasConceptScore W2015182248C2778212899 @default.
• W2015182248 hasConceptScore W2015182248C2778286760 @default.
• W2015182248 hasConceptScore W2015182248C2779980429 @default.
• W2015182248 hasConceptScore W2015182248C2780643987 @default.
• W2015182248 hasConceptScore W2015182248C2909801847 @default.
• W2015182248 hasConceptScore W2015182248C2989005 @default.
• W2015182248 hasConceptScore W2015182248C2994044699 @default.
• W2015182248 hasConceptScore W2015182248C33923547 @default.
• W2015182248 hasConceptScore W2015182248C71924100 @default.
• W2015182248 hasConceptScore W2015182248C94375191 @default.
• W2015182248 hasIssue "1" @default.
• W2015182248 hasLocation W20151822481 @default.
• W2015182248 hasLocation W20151822482 @default.

• next